Ibogaine Archives - Page 2 of 6

Best practices to prevent misuse of opioid settlement funds

Commentary by Layal Bou Harfouch and Mariana Trujillo

Psychedelics Policy Newsletter: DEA considers rescheduling psilocybin, FDA releases rejection decision, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — October 2025

Commentary by Gregory Ferenstein

Psychedelics Policy Newsletter: RFK Jr. gives hopeful approval timeline, Arizona advances ibogaine, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — August 2025

Commentary by Gregory Ferenstein

Arizona joins Texas in ibogaine clinical trial research push for veteran, first responder mental health

Commentary by Leonard Gilroy

Psychedelics Policy Newsletter: FDA prioritizes drug reform for psychedelics, Texas advances ibogaine research, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

State psychedelics legalization and policy roundup — June 2025

Commentary by Gregory Ferenstein

Texas Senate Bill 2308 could advance ibogaine as a treatment for opioid use disorder

Testimony by Madison Carlino

More Ibogaine